The exciting news about Emergent BioSolutions (NYSE: EBS) will be shared on Wednesday 6th November 2024. Investors and analysts are eagerly waiting to hear about the company's financial performance for the third quarter of 2024. This significant announcement will happen after market close.
Financial analysts on Wall Street are predicting that the organization is about to reveal an estimated $0.14 profit per share for the quarter. Additionally, the company is projected to announce a total revenue of $297.5 million for this period.
The earnings report for the corresponding quarter in the previous year showcased a per-share loss of $0.87. This considerable sum was attributed to the company's total revenue, which reached an impressive $270.5 million during that specific quarter.
The company's full-year performance projections, as provided by Wall Street analysts, suggest a total revenue of $1.12 billion. Further, they expect the earnings per share to achieve loss of $1.67 for the fiscal year.
The business has scheduled a conference call on 6th November 2024 at 05:00 PM eastern time to discuss Q3 financial results.
Friday's trading saw Emergent BioSolutions (EBS) shares hit a low of $8.98 and a high of $9.42, with a day volume of 1.02 million shares. The stock closed the regular trading session at $9.12, reflecting 0.66 percent rise.
